Duane Attree

Amabel has a depth of experience across the medical research and biopharma space, from pre-clinical R&D through to supporting commercialization with business intelligence and analyst insights. She has led proposal support at the University of Melbourne to grow the pipeline of MRFF submissions to secure revenue and funding success for impact-driven programs. Previously as a consultant at Clarivate Analytics she supported the growth of the life sciences business in ANZ with custom projects, presales engagement, and professional training and workshops to support business intelligence and regulatory compliance, Amabel has hands-on R&D experience, with a PhD in vaccine design she has developed several novel vaccines and immunostimulatory agents and is an inventor for an anti-viral under commercial development. As a scientist for a University spin-out she project managed global studies for a new investigational oncology vaccine for the first in man phase 1 clinical trials.